| Patents for C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815) |
|---|
| 08/02/2000 | CN1261876A N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases |
| 08/02/2000 | CN1055081C Pull-push olefine and its synthesis process and use |
| 08/01/2000 | US6096908 Tetrahydro-2-acetoxy-6-trifluoromethyl-5-hydroxypyran optical isomers |
| 08/01/2000 | US6096904 Discodermolides |
| 08/01/2000 | US6096888 Anthracyclinone derivatives and their use in amyloidosis |
| 08/01/2000 | US6096780 Antiviral compound useful for treating hiv viruses |
| 07/27/2000 | WO2000043352A1 A method for the synthesis of compounds of formula 1 and derivatives thereof |
| 07/27/2000 | WO2000023429A3 Stereoselective process for producing cryptophycins |
| 07/27/2000 | CA2359076A1 A method for the synthesis of compounds of formula 1 and derivatives thereof |
| 07/26/2000 | EP1021457A1 Method for the site specific synthesis of novel 3-hydroxypyridin-4(1h)-ons derivatives from aminomonosaccharides or aminoitols, products obtained by this method and their applications |
| 07/26/2000 | CN1054851C 3-aryl-pyrone derivatives and their preparing methods and uses as pesticides and herbicides |
| 07/20/2000 | WO2000014097A3 Novel pyranoses |
| 07/18/2000 | US6090953 Pyronin antibacterials, process and novel intermediates thereto |
| 07/12/2000 | EP1017658A1 Benzyl-biphenyls and analogous compounds and the application thereof in order to treat arteriosclerosis and dyslipidaemia |
| 07/11/2000 | US6087392 (4-arylsulfonylamino)-tetrahydropyran-4-carboxylic acid hydroxamides |
| 07/11/2000 | US6087359 A matrix metalloprotease enzyme inhibitor |
| 07/06/2000 | WO2000039088A1 Glucagon antagonists/inverse agonists |
| 07/06/2000 | WO2000038786A2 Use of cyclooxygenase 2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | WO2000038730A2 Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents for combination therapy in neoplasia |
| 07/06/2000 | WO2000038719A1 Use of a matrix metalloproteinase inhibitor and an integrin antagonist in the treatment of neoplasia |
| 07/06/2000 | WO2000038718A2 Use of matrix metalloproteinase inhibitor together with an antineoplastic agents, optionally also together with radiation, in the treatment of neoplasia |
| 07/06/2000 | WO2000038717A2 Use of a matrix metalloproteinase inhibitor and radiation as a combined treatment of neoplasia |
| 07/06/2000 | WO2000038715A2 Use of an integrin antagonist and radiation in the treatment of neoplasia |
| 07/06/2000 | WO2000038665A2 Use of an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356929A1 Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combonation therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356748A1 Method of using an integrin antagonist and radiation therapy as combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356606A1 Method of using a cyclooxygenase-2 inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356462A1 Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356459A1 Method of using a matrix metalloproteinase inhibitor and radiation therapy as combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356402A1 Use of a matrix metalloproteinase inhibitor and an integrin antagonist in the treatment of neoplasia |
| 07/06/2000 | CA2356302A1 Method of using a cyclooxygenase-2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia |
| 07/05/2000 | EP1015441A1 Process to produce 4-hydroxy-2-oxo-pyrane derivatives useful as protease inhibitors |
| 07/05/2000 | EP1015417A1 Compounds containing six-membered rings, processes for their preparation, and their use as medicaments |
| 07/05/2000 | CN1258675A Process and intermediate for producing 5-lipoxidase inhibitor |
| 06/29/2000 | WO2000037437A1 Novel herbicides |
| 06/29/2000 | WO2000037107A2 Use of cyclooxygenase-2 inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combination treatment of neoplasia |
| 06/29/2000 | WO2000010965A3 Quaternary ammonium salts and their use as anti-hiv agents |
| 06/29/2000 | DE19859251A1 Verfahren zur Herstellung von substituierten Chromanderivaten A process for preparing substituted chroman derivatives |
| 06/29/2000 | CA2356426A1 Method of using a cyclooxygenase-2 inhibitor and a matrix metalloproteinase inhibitor as a combination therapy in the treatment of neoplasia |
| 06/28/2000 | EP1013652A2 Process for preparation of substituted chromanderivatives |
| 06/28/2000 | CN1053902C Hydrogenation process |
| 06/27/2000 | US6080555 Incubating a genetically engineered polyketide synthase modified by deactivation of catalytic domain of ketosynthase of first module with diketide substrate and optionally recovering the produced polyketide; for generating libraries |
| 06/27/2000 | CA2180000C Amino-acid amide derivatives, method for producing the same, and agricultural or horticultural fungicides |
| 06/22/2000 | WO2000035858A1 Phenylglycine derivatives |
| 06/22/2000 | WO2000035440A1 N-formyl hydroxylamine derivatives as antibacterial agents |
| 06/22/2000 | WO2000035288A1 Cyclohexenone oxime ether / (glyphosates / gluphosinates) suspension concentrates |
| 06/22/2000 | CA2289422A1 Process and intermediates for preparing 5-lipoxygenase inhibitors |
| 06/21/2000 | EP1009737A2 Sulfonylamino substituted hydroxamic acid derivatives as metalloprotease inhibitors |
| 06/20/2000 | US6077963 Process to produce a protease inhibitor |
| 06/20/2000 | US6077696 Recombinant production of novel polyketides |
| 06/15/2000 | WO2000034264A1 Process for producing simvastatin |
| 06/14/2000 | EP1008592A2 Cyclic amide derivatives which inhibit cathepsin K |
| 06/14/2000 | EP1007033A1 Lymphocyte function antigen-1 antagonists |
| 06/14/2000 | EP1007032A1 4-cyano-4-deformylsordaricin derivatives |
| 06/13/2000 | US6074944 Methods for priming wafers employed in integrated circuit devices using dihydropyrane |
| 06/08/2000 | WO2000032585A1 Process for the preparation of simvastatin and analogs thereof |
| 06/07/2000 | EP1005465A2 New epothilone derivatives, method for producing same and their pharmaceutical use |
| 06/07/2000 | EP0840606B1 Di- and trivalent small molecule selectin inhibitors |
| 06/06/2000 | US6072089 Reacting 2-butenal derivative with formaldehyde, hydrogenating mixture of products without separating |
| 06/06/2000 | US6071937 Oxymethoxy-3-aryl-pyrone derivatives |
| 06/06/2000 | CA2114830C Lactone compound and process of production thereof |
| 06/02/2000 | WO2000031548A1 Prevention and treatment of amyloid-associated disorders |
| 06/02/2000 | WO2000031059A1 2-acylamino-2-deoxy-glucono-1,5-lactones, method for obtaining same, compositions comprising them and uses |
| 06/02/2000 | CA2351664A1 2-acylamino-2-deoxy-glucono-1,5-lactones, method for obtaining same, compositions comprising them and uses |
| 06/02/2000 | CA2349229A1 Prevention and treatment of amyloid-associated disorders |
| 05/31/2000 | EP1003846A1 Protease inhibitors |
| 05/31/2000 | EP1003720A1 Aryloxyarylsulfonylamino hydroxamic acid derivatives |
| 05/31/2000 | EP0633775B1 Compounds useful for treating inflammatory diseases and for inhibiting production of tumor necrosis factor |
| 05/31/2000 | CN1255161A Protease inhibitors |
| 05/30/2000 | US6068834 Orally administering a melanins reducing oxy phenol compound to the mammal for lightening the mammalian skin; tyrosinase inhibitor |
| 05/25/2000 | WO2000029401A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 05/25/2000 | WO2000028981A2 Methods for treating, preventing, and reducing the risk of the onset of alzheimer's disease using an hmg coa reductase inhibitor |
| 05/25/2000 | CA2350420A1 Methods for treating, preventing, and reducing the risk of the onset of alzheimer's disease using an hmg coa reductase inhibitor |
| 05/25/2000 | CA2348459A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 05/24/2000 | EP1001930A2 N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases |
| 05/24/2000 | EP0662966B1 Synthesis of n-acetyl neuraminic acid derivatives |
| 05/24/2000 | CN1254337A N-hydroxy 4-sulfonyl butyramide compounds |
| 05/24/2000 | CN1052721C Jinghong goniothalamicin A and its preparation method and use |
| 05/18/2000 | WO2000027836A1 Tetrahydropyrane-2,4-diols, method for producing them and their use |
| 05/18/2000 | WO2000004892A3 Coadministration of acat and mmp inhibitors for the treatment of atherosclerotic lesions |
| 05/17/2000 | EP1000172A1 Detection of targets with green fluorescent protein and fluorescent variants thereof |
| 05/17/2000 | EP1000012A1 Process for converting propargylic amine-n-oxides to enaminones |
| 05/17/2000 | CN1253559A Sulfonyl divalent aryl alpha-hydroxamic acid compounds |
| 05/17/2000 | CN1253474A Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 05/17/2000 | CN1052481C Platelet activating factor antagonist and preparation thereof |
| 05/16/2000 | US6063939 Process for preparing unsaturated cyclic ethers |
| 05/16/2000 | US6063928 Antiinflammatory agents, antiallergens, cardiotonic agents |
| 05/16/2000 | US6063816 Hydroxamic acid compounds |
| 05/16/2000 | CA2144342C Synthesis of n-acetyl neuraminic acid derivatives |
| 05/11/2000 | WO2000025606A1 Solid delivery systems for aroma ingredients |
| 05/11/2000 | DE19911198A1 Tetrahydropyran-2,4-diole, Verfahren zu deren Herstellung und Verwendung Tetrahydropyran-2,4-diols, to processes for their preparation and use |
| 05/11/2000 | CA2346897A1 Solid delivery systems for aroma ingredients |
| 05/10/2000 | CN1252790A N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 05/10/2000 | CN1252713A N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 05/04/2000 | WO2000024743A1 Pyrano, piperidino, and thiopyrano compounds and methods of use |
| 05/04/2000 | WO2000024730A1 Organic vanadium(iii) complexes and their use |
| 05/04/2000 | WO2000024729A1 5-halogen-3-phenyl-pyrone |
| 05/04/2000 | WO2000024728A1 Microbial transformation product |
| 05/04/2000 | WO1999067430A3 Analytic substrates and antioxidative agents |
| 05/04/2000 | CA2348576A1 Pyrano, piperidino, and thiopyrano compounds and methods of use |